Canadian Competition Bureau chief takes a tough stance on pay-to-delay agreements

Published date08 October 2014
Law FirmPatterson Belknap Webb & Tyler LLP
AuthorDeirdre McEvoy
Subject MatterAntitrust Provisions,Canada,Competition,Pay-to-Delay System,Pharmaceutical Industry,Prescription Drugs

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT